RxSight, Inc.
RXST
$8.43
$0.212.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -32.25M | -26.55M | -27.46M | -30.69M | -36.77M |
| Total Depreciation and Amortization | 3.23M | 3.27M | 3.62M | 4.19M | 4.17M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 4.00K |
| Total Other Non-Cash Items | 21.13M | 17.58M | 16.10M | 14.37M | 14.27M |
| Change in Net Operating Assets | -8.93M | -10.77M | -9.21M | -8.85M | -11.30M |
| Cash from Operations | -16.82M | -16.47M | -16.95M | -20.99M | -29.62M |
| Capital Expenditure | -4.06M | -4.05M | -5.44M | -6.18M | -5.73M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.63M | -98.68M | -93.87M | -89.88M | -63.80M |
| Cash from Investing | 27.57M | -102.73M | -99.31M | -96.07M | -69.53M |
| Total Debt Issued | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Repaid | -39.00K | -47.00K | -61.00K | -83.00K | -20.11M |
| Issuance of Common Stock | 9.59M | 119.46M | 128.92M | 129.51M | 139.61M |
| Repurchase of Common Stock | -4.05M | -4.05M | -4.77M | -4.77M | -3.22M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -311.00K | -768.00K | -768.00K | -754.00K | -1.49M |
| Cash from Financing | 5.18M | 114.59M | 123.32M | 123.91M | 114.79M |
| Foreign Exchange rate Adjustments | 15.00K | 0.00 | -9.00K | 11.00K | -1.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -1.00K | 0.00 |
| Net Change in Cash | 15.95M | -4.61M | 7.05M | 6.86M | 15.64M |